Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
Atbasoglu
E Cem
EC
Ozguven
Halise Devrimci
HD
Can Saka
Meram
M
Goker
Ceren
C
D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003128:Coma / Q000139:chemically induced* / Q000175:diagnosis; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D007964:Leukocytosis / Q000175:diagnosis; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D013469:Sulpiride; D000077582:Amisulpride; D003402:Creatine Kinase